Mode
Text Size
Log in / Sign up

Educational films for gestational diabetes do not reduce adverse perinatal outcomes in Uganda and India trial

Educational films for gestational diabetes do not reduce adverse perinatal outcomes in Uganda and In…
Photo by Matias Eduardo / Unsplash
Key Takeaway
Note that educational films did not reduce adverse perinatal outcomes in pregnant women with gestational diabetes.

This cluster randomised trial was conducted across 30 government-funded health facilities in Uganda and India involving pregnant women and healthcare providers. Screening included 5495 participants in Uganda and 12045 in India, with 5102 and 10899 respectively participating.

The intervention consisted of a package of 7 interconnected culturally-tailored educational films shared with pregnant women and health professionals, compared against usual care. The primary outcome was an individual self-reported composite of unplanned caesarean section, stillbirth or neonatal death, or neonatal hospitalisation. In Uganda, the composite adverse perinatal outcome occurred in 19.7% of the control arm versus 19.8% in the intervention arm (PR 1.00, 95% CI 0.87 to 1.14). In India, rates were 29.5% in the control arm versus 30.6% in the intervention arm (PR 1.04, 95% CI 0.96 to 1.11). The pooled relative risk was 1.03 (95% CI 0.97 to 1.10).

Safety data regarding adverse events, serious adverse events, and discontinuations were not reported. Key limitations include loss to follow-up of 31.7% in Uganda and 12.1% in India. Participants, facility, and trial staff were not blinded, though data analysts were blinded to group allocation.

Practice relevance is limited as the intervention did not reduce incidence of adverse perinatal outcomes. Future evaluations should assess educational films delivered alongside more intensive intervention components.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
INTRODUCTION: Gestational diabetes mellitus (GDM) is associated with a high risk of adverse perinatal outcomes. We evaluated whether a film-based educational intervention for pregnant women and healthcare providers to improve timely detection and management of GDM could reduce the incidence of adverse perinatal outcomes. METHODS: Two parallel-group cluster randomised trials were conducted in Uganda and India. A package of 7 interconnected culturally-tailored educational films was developed following formative research. 30 government-funded health facilities (clusters) in each country were randomised (1:1) to intervention or control arm. In intervention facilities (15 in each country), films were shared with pregnant women and health professionals; control facilities (15 in each country) received usual care. The outcome was an individual self-reported composite of unplanned caesarean section, stillbirth or neonatal death, or neonatal hospitalisation. Mixed effects models were used in an intention-to-treat analysis with multiple imputation by chained equations to address missing data. Analyses were performed separately for each country; random-effects meta-analysis was used to calculate pooled prevalence ratios (PRs). Data analysts were blinded to group allocation, but participants, facility and trial staff were not. RESULTS: In Uganda, 5495 women were screened between May 2021 and April 2022, and 5102 (92.8%) participated in the trial. In India, 12 045 women were screened between July 2021 and January 2022, and 10 899 (90.5%) participated. Loss to follow-up was 31.7% in Uganda and 12.1% in India. In Uganda, the prevalence of the composite adverse perinatal outcome was 19.7% in the control arm and 19.8% in the intervention arm (PR 1.00, 95% CI 0.87 to 1.14). For India, the prevalence was 29.5% and 30.6%, respectively (PR 1.04, 95% CI 0.96 to 1.11). The pooled PR across both countries was 1.03 (95% CI 0.97 to 1.10). CONCLUSIONS: A film-based intervention did not reduce the incidence of adverse perinatal outcomes associated with GDM. Future evaluations should assess educational films delivered alongside more intensive intervention components. TRIAL REGISTRATION NUMBERS: NCT03937050, ISRCTN96432637.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.